Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» FDA Grants Amgen Priority Review Designation For Ivabradine For The Treatment Of Chronic Heart Failure
FDA Grants Amgen Priority Review Designation For Ivabradine For The Treatment Of Chronic Heart Failure
FDA Grants Amgen Priority Review Designation For Ivabradine For The Treatment Of Chronic Heart Failure
Submitted by
admin
on August 27, 2014 - 10:00am
Source:
Yahoo
News Tags:
FDA
chronic heart failure
Amgen
ivabradine
Headline:
FDA Grants Amgen Priority Review Designation For Ivabradine For The Treatment Of Chronic Heart Failure
Do Not Allow Advertisers to Use My Personal information
